[Pharmacokinetics of rifamycin]

Area of Science:

• Pharmacology
• Microbiology
• Drug Metabolism

Background:

• Rifamycin is a crucial antibiotic with broad-spectrum activity.
• Understanding its pharmacokinetic profile is essential for optimizing therapeutic efficacy.
• Previous studies have indicated variable absorption and distribution patterns.

Purpose of the Study:

• To investigate the pharmacokinetic behavior of rifamycin in experimental animals.
• To determine tissue distribution, excretion, and protein binding characteristics.
• To compare rifamycin pharmacokinetics across different administration routes.

Main Methods:

• Antibiotic administration via intravenous, intramuscular, and oral routes in rats and rabbits.
• Quantification of rifamycin levels in plasma and various tissues (including liver).
• Analysis of urinary excretion and blood serum/tissue homogenate binding.

Main Results:

• Parenteral administration led to high rifamycin levels in rats and rabbits.
• Satisfactory penetration into rat tissues observed irrespective of administration route.
• Highest antibiotic concentrations detected in the liver; minimal urinary excretion (approx. 6% in 4 hours).
• Extrarenal clearance was slightly lower than plasmic clearance but significantly higher than renal clearance.
• Significant protein binding observed in human (68%), ox (64%), and rabbit (56%) serum, and rat organ homogenates (34-72%).

Conclusions:

• Rifamycin exhibits favorable pharmacokinetic properties, including good tissue penetration and high liver accumulation.
• The drug is primarily cleared via non-renal routes, with substantial protein binding.
• Findings support the potential for effective therapeutic use of rifamycin across various administration routes.